Zobrazeno 1 - 10
of 54
pro vyhledávání: '"M I, Colnaghi"'
Publikováno v:
Scopus-Elsevier
Trop-2 is a cell surface structure recognized by the 162-46.2 mAb and expressed by most human carcinomas. Since the 162-46.2 mAb works poorly in immunoprecipitation, to characterize the structure of Trop-2 we searched for other mAbs directed against
Autor:
S. BUTO', C. GHIRELLI, P. AIELLO, E. TAGLIABUE, E. ARDINI, A. MAGNIFICO, M. E. SOBEL, M. I. COLNAGHI AND S. MENARD, MONTUORI, NUNZIA
The 67-kDa laminin receptor (67LR) is an important tumor marker whose molecular structure has not yet been fully elucidated. To shed new light on this molecule, we raised a series of eight new monoclonal antibodies, designated MPLR1 to 8, directed ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3730::952196f2a46f3e42c2e86fc41f226385
http://hdl.handle.net/11588/150874
http://hdl.handle.net/11588/150874
Autor:
E, Adobati, A, Zacchetti, M E, Perico, F, Cremonesi, G, Rasi, P S, Vallebona, M, Hagenaars, P J, Kuppen, I, Pastan, L, Panza, G, Russo, M I, Colnaghi, S, Canevari
Publikováno v:
The Histochemical journal. 31(11)
CaMBr1 is a blood group-related tumour-associated antigen, whose pattern of expression provides a therapeutic window for passive or active immunotherapy and points to the promise of a vaccine against carcinomas overexpressing this antigen. In this co
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology. 79(7)
Angiogenesis is an important prognostic factor in invasive breast carcinoma. We analyzed sera and tumor samples from 36 patients with primary breast carcinomas to determine the relationship between tumor vascularity, vascular endothelial growth facto
Publikováno v:
European journal of cancer (Oxford, England : 1990). 34(12)
Autor:
S, Miotti, D R, Negri, O, Valota, M, Calabrese, R L, Bolhuis, J W, Gratama, M I, Colnaghi, S, Canevari
Publikováno v:
International journal of cancer. 84(1)
More than 60% of cancer patients injected with intact murine monoclonal antibody (MAb) develop a humoral response against the antigen even after a single dose. Analysis of a series of 35 ovarian-cancer patients entered in phase-I and -II clinical stu
Autor:
D, Morelli, D, Lazzerini, S, Cazzaniga, P, Squicciarini, P, Bignami, J A, Maier, L, Sfondrini, S, Ménard, M I, Colnaghi, A, Balsari
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 4(5)
Angiogenesis is a critical determinant of tumor growth. Tumor cells produce or induce angiogenic molecules that act specifically on endothelial cells (ECs) but also release angiostatic molecules. Thus, tumor angiogenesis represents a net balance betw
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 38(9)
Radioimmunodetection of tumor can be improved by introducing a two-step system in which radiolabeled streptavidin is administrated after the injection of a biotinylated monoclonal antibody (MAb) (two-step) or radiolabeled biotin is injected after bio
Publikováno v:
International journal of cancer. 72(4)
The lung carcinoma cell line Calu3, which overexpresses the c-erbB-2 oncogene, was stably transfected with antisense (AS) cDNA constructs encompassing different regions of the c-erbB-2 gene. Transfected cells were analyzed for their tumorigenic prope
Autor:
S, Ménard, G, Tomasic, P, Casalini, A, Balsari, S, Pilotti, N, Cascinelli, B, Salvadori, M I, Colnaghi, F, Rilke
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 3(5)
Infiltration by lymphoid cells is a common feature of many human tumors, including breast carcinomas, and the degree of infiltration has been suggested to be a measure of the host immune response. Our analyses in a series of 1919 cases of primary duc